Tin tức & Cập nhật
Xem bài viết Nhi khoa
Xem
Chỉ hiển thị Multimedia

Glycaemic control in early T2D improved with novel oral GLP-1 receptor agonist
21 Jul 2025
bởiJairia Dela Cruz
For adults with early type 2 diabetes (T2D) not adequately controlled by diet and exercise alone, treatment with the investigational small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist orforglipron yields significant reductions in glycated haemoglobin levels, according to data from the phase III ACHIEVE-1 trial.








